Latest Europe News

Kuniko Limited has streamlined its Norwegian battery metals portfolio, pursued non-dilutive green funding, and forged AI satellite data partnerships, setting the stage for growth in Europe’s critical minerals sector.

GreenX Metals advances its Tannenberg Copper Project with BHP funding and license expansion, while Greenland projects gain momentum amid soaring antimony prices. The company also confirms a £435 million arbitration award against Poland, facing ongoing legal challenges.

European Metals Holdings has achieved key regulatory milestones for its Cinovec Lithium Project, including EU Strategic Project status and a $36 million grant, positioning it as a pivotal supplier in Europe’s lithium supply chain.

Opyl Limited reports strong progress in AI-driven clinical trial optimisation with active commercial initiatives, strategic partnerships, and a planned capital raise to support growth amid tight cash reserves.

Desane Group Holdings has secured a seven-year lease extension with Signature Orthopaedics at its Lane Cove property, guaranteeing $5 million in rental income through 2032. This deal reinforces Desane’s strategy to maintain stable medium-term cash flows.

OncoSil Medical has reported a remarkable 233% increase in dose sales for Q3 FY25, alongside significant regulatory approvals and strategic expansions that position the company for accelerated growth.

Echo IQ Limited marked a pivotal quarter with FDA clearance for EchoSolv AS, strategic US partnerships, and a clear path toward reimbursement and broader commercialisation.

Alexium International Group reported a challenging Q3 FY2025 with lower revenues due to softness in the US bedding market, while making significant technological strides and maintaining a solid funding position.

Iondrive Limited confirms strong financial metrics for its proprietary DES battery recycling technology, progressing pilot plant development and divesting exploration assets to sharpen focus on commercialisation.

Way2VAT Ltd reported a robust 54% increase in Q1 FY25 revenue to A$1.05 million, driven by new client onboarding and higher VAT claim volumes, alongside strategic cost reductions and fresh credit facilities.

Medical Developments International reported a robust Q3 FY25 with $8.9 million revenue and $1.7 million operating cashflow, driven by strong Penthrox demand and pricing. New distribution agreements in France and Switzerland position the company for further European expansion.

GreenHy2 Limited reports a strategic push in Europe with new contracts for its advanced supercapacitor and hydrogen storage technologies, alongside a cash position of $814K and four quarters of funding runway.